Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial
- Type
- Retraction
- Notice date
- 3/12/2021 0:00
- Journal
- European journal of Endocrinology (European Federation of Endocrine Societies)
- Publisher
- BioScientifica
- Notice DOI
- 10.1530/eje-20-0857z
- Original paper DOI
- 10.1530/eje-20-0857